Co-Authors
This is a "connection" page, showing publications co-authored by Linlin Bao and Fengdi Li.
Connection Strength
1.061
-
Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza. Signal Transduct Target Ther. 2021 05 20; 6(1):200.
Score: 0.237
-
Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020 05 08; 5(1):66.
Score: 0.220
-
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
Score: 0.220
-
Publisher Correction: A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2021 Feb; 590(7844):E23.
Score: 0.058
-
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature. 2020 10; 586(7830):572-577.
Score: 0.056
-
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020 08 14; 369(6505):818-823.
Score: 0.056
-
Age-related rhesus macaque models of COVID-19. Animal Model Exp Med. 2020 Mar; 3(1):93-97.
Score: 0.055
-
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset. J Infect Dis. 2017 06 15; 215(12):1807-1815.
Score: 0.045
-
[Clinical and Biological Character in Mouse Models for Middle East Respiratory Syndrome Generated by Transduction with Different Doses of DPP4 Molecule]. Bing Du Xue Bao. 2015 Nov; 31(6):593-600.
Score: 0.040
-
Treatment With Lopinavir/Ritonavir or Interferon-ß1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset. J Infect Dis. 2015 Dec 15; 212(12):1904-13.
Score: 0.039
-
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis. 2014 Jan 15; 209(2):236-42.
Score: 0.035